Please septerate into two parts. Two seperate disucssion boards. 1 page each. P

Please septerate into two parts. Two seperate disucssion boards. 1 page each.
Part 1 (1 page):What do you think of the regulatory policies in countries like Japan and China that mandate that a medical product seeking marketing approval have citizens of that country in clinical trials used to support the application?
Part 2 (1 page): What do you think of the fact that the members of the various review committees that make up South Africa’s MCC are not full-time employees? Does this have an impact on aspects of regulation other than waiting times?